(Q21195234)

English

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ

scientific article

In more languages

Statements

scholarly article

0 references

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ (English)

0 references

lymphangiogenesis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

breast carcinoma

1 reference

based on heuristic

inferred from title

breast carcinoma in situ

1 reference

based on heuristic

inferred from title

author name string

Martin Götte

1

author given names

Martin

author last names

Götte

1 reference

Dimensions Publication ID

18 August 2022

Christian Kersting

2

author given names

Christian

author last names

Kersting

1 reference

Dimensions Publication ID

18 August 2022

Isabel Radke

3

author given names

Isabel

author last names

Radke

1 reference

Dimensions Publication ID

18 August 2022

Ludwig Kiesel

4

author given names

Ludwig

author last names

Kiesel

1 reference

Dimensions Publication ID

18 August 2022

Pia Wülfing

5

author given names

Pia

author last names

Wülfing

1 reference

Dimensions Publication ID

18 August 2022

language of work or name

0 references

publication date

2007

0 references

Breast Cancer Research

0 references

9

0 references

1

0 references

R8

0 references

Endothelin receptors as novel targets in tumor therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

19 March 2017

Syndecans in tumor cell adhesion and signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

19 March 2017

Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

19 March 2017

Targeting the c-Met signaling pathway in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

19 March 2017

Relevance of breast cancer cell lines as models for breast tumours: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

19 March 2017

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

19 March 2017

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

19 March 2017

Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

19 March 2017

Functions of cell surface heparan sulfate proteoglycans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

7 April 2017

What's wrong with Bonferroni adjustments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

7 April 2017

Therapeutic value of glycosaminoglycans in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Endothelial cadherins and tumor angiogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Inhibitors of growth factor signalling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Cadherins and catenins in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

MET and MYC cooperate in mammary tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Current practical applications of diagnostic immunohistochemistry in breast pathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Syndecans in inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

E-cadherin as a prognostic indicator in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Mechanistic insights on the inhibition of tumor angiogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Expression of c-met is a strong independent prognostic factor in breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

12 September 2017

Syndecan-1 expression in epithelial cells is induced by transforming growth factor beta through a PKA-dependent pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

27 September 2017

Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

27 September 2017

The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

27 September 2017

Beta4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

27 September 2017

Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

27 September 2017

HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

27 September 2017

Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

27 September 2017

Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

27 September 2017

Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

27 September 2017

UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

27 September 2017

Ductal carcinoma in situ: a proposal for a new classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

27 September 2017

Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

30 May 2018

Hepatocyte growth factor is upregulated by low-density lipoproteins and inhibits endothelin-1 release

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

30 May 2018

Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

30 May 2018

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

30 May 2018

Inhibition by the soluble syndecan-1 ectodomains delays wound repair in mice overexpressing syndecan-1.

1 reference

https://api.crossref.org/works/10.1186%2FBCR1641

21 January 2018

High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.

1 reference

https://api.crossref.org/works/10.1186%2FBCR1641

21 January 2018

Prognostic value of syndecan-1 expression in breast cancer.

1 reference

https://api.crossref.org/works/10.1186%2FBCR1641

21 January 2018

Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis

1 reference

https://api.crossref.org/works/10.1186%2FBCR1641

21 January 2018

E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.

1 reference

https://api.crossref.org/works/10.1186%2FBCR1641

21 January 2018

Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy

1 reference

https://api.crossref.org/works/10.1186%2FBCR1641

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FBCR1641

21 January 2018

Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors

1 reference

https://api.crossref.org/works/10.1186%2FBCR1641

21 January 2018

C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu

1 reference

https://api.crossref.org/works/10.1186%2FBCR1641

21 January 2018

Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival.

1 reference

https://api.crossref.org/works/10.1186%2FBCR1641

21 January 2018

Altered expression of E-cadherin in breast cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR1641

21 January 2018

Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma

1 reference

https://api.crossref.org/works/10.1186%2FBCR1641

21 January 2018

Overexpression of Endothelin-A-receptor in breast cancer: regulation by estradiol and cobalt-chloride induced hypoxia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

29 November 2018

Endothelin-1, Endothelin-A- and Endothelin-B-receptor expression in preinvasive and invasive breast disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

29 November 2018

Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

29 November 2018

Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851383

29 November 2018

Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17244359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/BCR1641

0 references

Dimensions Publication ID

0 references

0 references

0 references

ResearchGate publication ID

0 references

Springer Nature article ID

10.1186/bcr1641

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21195234&oldid=1832489038"